To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The Annual Pink Out the Park, a partnership between the Barbara Ann Karmanos Cancer Institute , the Detroit Tigers and McLaren Health Care, the official health care system of the Detroit Tigers, was a massive hit on Saturday, June 8. A sea of pink took up the field of vision at Comerica Park as the Tigers faced the Milwaukee Brewers in the second game of a three-game series. Hundreds of breast cancer survivors were honored before and during the game by players and the Tiger faithful. For the 12 th year,...
The Barbara Ann Karmanos Cancer Institute , in partnership with the Detroit Tigers and McLaren Health Care, the official health care system of the Tigers, continues the tradition of “Pink Out the Park” during the Saturday, June 8 game against the Milwaukee Brewers at Comerica Park. This special event has raised awareness for breast health for the past 12 years, celebrating survivors and honoring the legacies of those who have fought courageously. Breast cancer survivors will take part in a special pre-g...
Researchers at the Barbara Ann Karmanos Cancer Institute took a deep dive into the significance of breast cancer screening and the recommendations for women who carry the pathogenic breast cancer gene- (BRCA) 1 and 2 variants. They concluded that there was 83% adherence to the National Comprehensive Cancer Network (NCCN) screening guidelines for women screened at the Women’s Wellness Clinic at the Karmanos Cancer Center in Detroit. The research study titled "Uptake of Screening and Risk-Reducing Recomme...